T2 BIOSYSTEMS INC's ticker is TTOO and the CUSIP is 89853L104. A total of 50 filers reported holding T2 BIOSYSTEMS INC in Q4 2019. The put-call ratio across all filers is 2.14 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $51 | -99.9% | 6,300 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $51,000 | 0.0% | 6,300 | 0.0% | 0.00% | -50.0% |
| Q2 2022 | $51,000 | -44.6% | 6,300 | -44.2% | 0.00% | +100.0% |
| Q1 2022 | $92,000 | +2966.7% | 11,300 | +126.0% | 0.00% | – |
| Q4 2021 | $3,000 | -40.0% | 5,000 | 0.0% | 0.00% | – |
| Q3 2021 | $5,000 | -16.7% | 5,000 | 0.0% | 0.00% | – |
| Q2 2021 | $6,000 | -25.0% | 5,000 | 0.0% | 0.00% | – |
| Q1 2021 | $8,000 | +33.3% | 5,000 | 0.0% | 0.00% | – |
| Q4 2020 | $6,000 | -14.3% | 5,000 | 0.0% | 0.00% | – |
| Q3 2020 | $7,000 | 0.0% | 5,000 | 0.0% | 0.00% | -100.0% |
| Q2 2020 | $7,000 | +133.3% | 5,000 | 0.0% | 0.00% | – |
| Q1 2020 | $3,000 | -50.0% | 5,000 | 0.0% | 0.00% | – |
| Q4 2019 | $6,000 | -57.1% | 5,000 | -5.7% | 0.00% | -100.0% |
| Q3 2019 | $14,000 | +27.3% | 5,300 | +42.5% | 0.00% | 0.0% |
| Q4 2018 | $11,000 | – | 3,720 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co. V, L.L.C. | 1,875,524 | $6,020,000 | 6.23% |
| Lagoda Investment Management, L.P. | 1,975,921 | $6,343,000 | 2.42% |
| Flagship Pioneering Inc. | 1,950,583 | $6,261,000 | 2.21% |
| TIGER MANAGEMENT L.L.C. | 1,737,085 | $5,576,000 | 1.10% |
| Aisling Capital LLC | 1,523,499 | $4,890,000 | 0.84% |
| Senvest Management, LLC | 2,837,946 | $9,110,000 | 0.72% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 208,190 | $668,000 | 0.10% |
| ELEMENT CAPITAL MANAGEMENT LLC | 71,616 | $230,000 | 0.05% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 536,802 | $1,723,000 | 0.02% |
| Ironwood Financial, llc | 6,034 | $19,000 | 0.01% |